Drug Type Monoclonal antibody |
Synonyms Huvap |
Target |
Mechanism VAP-1 inhibitors(Amine oxidase, copper containing inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Vapaliximab | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | - | - | |
Graft Rejection | Phase 1 | - | - | |
Graft Rejection | Phase 1 | - | - | |
Graft Rejection | Phase 1 | - | - | |
Inflammatory Bowel Diseases | Phase 1 | - | - | |
Inflammatory Bowel Diseases | Phase 1 | - | - | |
Inflammatory Bowel Diseases | Phase 1 | - | - | |
Rheumatoid Arthritis | Phase 1 | - | - | |
Rheumatoid Arthritis | Phase 1 | - | - | |
Rheumatoid Arthritis | Phase 1 | - | - |